CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients undergoing surgical thoracoscopy and resection of lung cancer. Safety is the primary objective of this study, followed ...
Phase 1
Philadelphia, Pennsylvania, United States
undergoing VATS (Video-Assisted Thoracoscopic Surgery) or RATS (Robotic-Assisted Thoracoscopic Surgery) resection of Stage I-II non-small cell lung...
Phase 2
Philadelphia, Pennsylvania, United States and 1 other location
to evaluate the safety and efficacy of abenacianine for injection, a tumor-targeted, activatable fluorescent imaging agent, to identify cancer...
Phase 3
Philadelphia, Pennsylvania, United States and 5 other locations
Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung...
Philadelphia, Pennsylvania, United States
given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer...
Phase 2, Phase 3
Philadelphia, Pennsylvania, United States and 31 other locations
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
Camden, New Jersey, United States and 90 other locations
Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized ...
Phase 2
Philadelphia, Pennsylvania, United States of America and 4 other locations
HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...
Phase 1
Philadelphia, Pennsylvania, United States and 21 other locations
Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common fo ...
Phase 2
Philadelphia, Pennsylvania, United States of America and 40 other locations
in combination with immune checkpoint inhibitor (ICI) atezolizumab with or without carboplatin in participants with extensive stage-small cell lung...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 58 other locations
Clinical trials
Research sites
Resources
Legal